EGF, HGF and FGF strongly antagonized the vemurafenib sensitivity only in some of V600EBRAF melanomas tested; HGF in 5, EGF in 3 and different FGFs in not more than 1 out of 8 melanoma cell lines [1]. Here, EGF is linked to melanoma.